Medtronic plc logo
Medtronic plc (MDT)
Compare

MDT Cash Flow Statement

Operating, investing, and financing cash flow analysis

MDT Quarterly Cash Flow Statement (USD)

Quarterly ReportTTM
04/24/2026
01/23/2026
10/24/2025
07/25/2025
04/30/2025
04/25/2025
01/24/2025
10/25/2024
Cash from Operations (CFO)
7.330B2.573B2.744B925.000M1.088B2.528B2.572B958.000M
4.800B1.243B1.143B1.374B1.040B1.057B1.294B1.270B
Depreciation & Amortization
2.242B0.00905.000M589.000M748.000M840.000M684.000M675.000M
457.000M95.000M94.000M182.000M86.000M89.000M98.000M159.000M
Change in Accounts Receivable
12.452B-287.000M87.000M6.389B6.263B-249.000M6.515B6.115B6.260B
Change in Inventory
Change in Accounts Payable
Change in Working Capital
-1.423B444.000M702.000M-1.422B-1.147B450.000M462.000M905.000M
Cash from Investing
-1.904B-488.000M-444.000M-468.000M-504.000M-459.000M-476.000M-404.000M
-406.000M-406.000M0.000.000.000.00-98.000M0.00
Cash from Financing
Debt Repayment
-1.035B-435.000M-105.000M-372.000M-123.000M-274.000M-181.000M-288.000M
-3.639B-908.000M-911.000M-910.000M-910.000M-897.000M-897.000M-897.000M
5.426B2.085B2.300B457.000M584.000M2.069B2.096B554.000M
Net Change in Cash
-2.824B802.000M-135.000M-1.273B-2.218B978.000M-154.000M83.000M

MDT Annual Cash Flow Statement (USD)

Annual Report
04/24/2026
04/30/2025
04/25/2025
04/30/2024
04/26/2024
04/30/2023
04/28/2023
04/30/2022
Cash from Operations (CFO)
7.330B7.044B6.787B6.039B7.346B
4.800B4.662B3.676B3.758B5.039B
Depreciation & Amortization
0.002.861B2.647B2.697B2.707B
457.000M429.000M393.000M355.000M359.000M
Change in Accounts Receivable
-200.000M-433.000M6.515B-391.000M6.128B-576.000M5.998B-477.000M
Change in Inventory
Change in Accounts Payable
Change in Working Capital
-1.423B-1.054B-484.000M-967.000M-889.000M
Cash from Investing
-1.904B-1.859B-1.587B-1.459B-1.368B
-406.000M-98.000M-211.000M-1.867B-91.000M
Cash from Financing
Debt Repayment
-1.035B-3.235B-2.138B-645.000M-2.544B
-3.639B-3.589B-3.666B-3.616B-3.383B
5.426B5.185B5.200B4.580B5.978B
Net Change in Cash
-269.000M934.000M-259.000M-2.171B121.000M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha